Determination of methotrexate in biological fluids and a parenteral injection using terbium-sensitized method

Iranian Journal of Pharmaceutical Research

Volumn 10, Issue 4, 2011, Pages 695-704

  Jouyban, Abolghasem ^a   Shaghaghi, Masoomeh ^b   Manzoori, Jamshid L ^b   Soleymani, Jafar ^c   Vaez Gharamaleki, Jalil ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

^c Kimia Research Institute   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1,10 Phenanthroline; Injection solution; Methotrexate; Serum; Terbium sensitized; Urine

Indexed keywords

EBETREX; METHOTREXATE; TERBIUM; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG PURITY; DRUG URINE LEVEL; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PH; REPRODUCIBILITY; TEMPERATURE DEPENDENCE;

EID: 84859540236     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Sabry SM, Abdel-Hady M, Elsayed M, Fahmy OT and Maher HM. Study of stability of methotrexate in acidic solution spectrofluorimetric determination of methotrexate in pharmaceutical preparations through acid-catalyzed degradation reaction. J. Pharm. Biomed. Anal. (2003) 32: 409-423.
2. Bleyer WA. The clinical pharmacology of methotrexate: New applications of an old drug. Cancer (1978) 41: 36-51.
3. Moghbel A, Zand-Moghaddamb A, Rezaee S and Pedram M. High-performance liquid chromatography determination of methotrexate in plasma. Iranian J. Pharm. Res. (2003) 2: 149-152.
4. Ranganathan P and McLepd HL. Methotrexate pharmacogenetics. Arthritis Rheum. (2006) 54: 1366-1377.
5. Pavy S, Constantin A, Pham T, Gossec L, Maillefert JF, Cantagrel A, Combe B, Flipo RM, Goupille P, Le Loët X, Mariette X, Puéchal X, Schaeverbeke T, Sibilia J, Tebib J, Wendling Dand Dougados M. Methotrexate therapy for rheumatoid arthritis: Clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine (2006) 73: 388-395.
6. Vahid Roudsari F, Ayati S, Saghafy N and Shakeri M. Misoprostol alone or in combination with methotrexate for termination of pregnancy at first trimester. Iranian J. Pharm. Res. (2010) 9: 89-94.
7. Levitt M, Mosher MB, DeConti RC, Farber LR, Skeel RT, Marsh JC, Mitchell MS, Papac RJ, Thomas ED and Bertino JR. Improved therapeutic index of methotrexate with «leucovorin rescue». Cancer Res. (1973) 33: 1729.
8. Rodri{dotless}guez Flores J, Castaneda Penalvo G, Espinosa Mansilla A and Rodri{dotless}guez Gomez MG. Capillary electrophoretic determination of methotrexate, leucovorin and folic acid in human urine. J. Chromatogr. B (2005) 819: 141-147.
9. Gao L, Wu Y, Liu J and Ye B. Anodic voltammetric behaviors of methotrexate at a glassy carbon electrode and its determination in spiked human urine. J. Electroanal. Chem. (2007) 610: 131-136.
10. Swierkot J and Szechinski J. Methotrexate in rheumatoid arthritis. Pharmacol. Rep. (2006) 58: 473-492.
11. Henghe Tian MD, Bruce N and Cronstein MD. Understanding the mechanisms of action of methotrexate. Bull NYU Hosp. Joint Dis. (2007) 65: 168-173.
12. Fleisher M. Antifolate analogs: Mechanism of action, analytical methodology, and clinical efficacy. Ther. Drug Monit. (1993) 15: 521-529.
13. Pesce MA and Bodourian SH. Evaluation of a fluorescence polarization immunoassay procedure for quantitation of methotrexate. Ther. Drug Monit. (1986) 8: 115-121.
14. Hayashi H, Fujimaki C, Tsuboi S, Matsuyama T, Daimon T and Itoh K. Application of fluorescence polarization immunoassay for determination of methotrexate-poltglutamates in rheumatoid arthirits patients. Tohoku J. Exp. Med. (2008) 215: 95-101.
15. Falk LC, Clark DR, Kalman SM and Long TF. Enzymatic assay for methotrexate in serum and cerebrospinal fluid. Clin. Chem. (1976) 22: 785-788.
16. Buice RG, Evans WE, Karas J, Nicholas CA, Sidhu P, Straughn AB, Meyer MC and Crom WR. Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography. Clin. Chem. (1980) 26: 92-98.
17. Raso V and Schereider R. A rapid and specific radioimmunoassay for methotrexate. Cancer Res. (1975) 35: 1407-1410.
18. McCruddena EA and Tettb SE. Improved high-performance liquid chromatography determination of methotrexate and its major metabolite in plasma using a poly(styrene-divinylbenzene) column. J. Chromatogr. B (1999) 721: 87-92.
19. Duran Meras I, Espinosa Mansilla A and Rodriguez Gomez M. Determination of methotrexate, several pteridines, and creatinine in human urine, previous oxidation with potassium permanganate, using HPLC with photometric and fluorimetric serial detection. Anal. Biochem. (2005) 346: 201-209.
20. Komeilizadeh H, Foroutan SM, Zarghi A and Shafaati A. Quantification of Polyethylene Glycol Esters of Methotrexate and Determination of Their Partition Coefficients by Validated HPLC Methods. Iranian J. Pharm. Res. (2009) 8: 27-31.
21. Li H, Luo W, Zengb Q, Lin Z, Luo H and Zhang Y. Method for the determination of blood methotrexate by high performance liquid chromatography with online post-column electrochemical oxidation and fluorescence detection. J. Chromatogr. B (2007) 845: 164-168.
22. Kuo CU, Wu HL, Kou HS, Chiou SS, Wu DC and Wu SM. Simultaneous determination of methotrexate and its eight metabolites in human whole blood by capillary zone electrophoresis. J. Chromatogr. A (2003) 1014: 93-101.
23. Chakrabarti SG and Bernstein IA. A simplified fluorometric method for determination of plasma methotrexate. Clin. Chem. (1969) 15: 1157-1161.
24. Chen S, Zhang Z, He D, Hu Y, Zheng H and He C. Flow-injection-electrochemical oxidation fluorimetry for determination of methotrexate. Luminescence (2007) 22: 338-342.
25. Wang F, Wu Y, Liu J and Ye B. DNA Langmuir-Blodgett modified glassy carbon electrode as voltammetric sensor for determinate of methotrexate. Electrochim. Acta (2009) 54: 1408-1413.
26. 3+ complex and DNA. J. Agric. Food Chem. (2005) 53: 6207-6212.
27. Tong CL, Xiang GH, Huang DJ and Liu WP. Determination of ofloxacin by the terbium(III) ion fluorescence probe sensitized by the surfactant. Chin. J. Anal. Chem. (2004) 32: 619-621.
28. Lis S. Luminescence spectroscopy of lanthanide (III) ions in solution. J. Alloys Compd. (2002) 341: 45-50.
29. Georges J. Lanthanide-sensitized luminescence and applications to the determination of organic analytes. Analyst (1993) 118: 1481-1486.
30. 3- (ODA: oxydiacetate, phen: 1,10-phenanthroline). J. Photochem. Photobiol. A: Chem. (2005) 174: 28-37.
31. Sasirekha V, Umadevi M and Ramakrishnan V. Solvatochromic study of 1,2-dihydroxyanthraquinone in neat and binary solvent mixtures. Spectrochim. Acta A (2008) 69: 148-155.
32. Thipperudrappa J, Biradar DS, Lagare MT, Hanagodimath SM, Inamdar SR and Kadadevaramath JS. Fluorescence quenching of BPBD by aniline in benzene-acetonitrile mixtures. J. Photochem. Photobiol. A: Chem. (2006) 177: 89-93.
33. ICH Harmonised Tripartite Guideline, validation of analytical procedures: text and methodology, Q2 (R1). Website. http://www.ich.org/[4 May 2010].